Jf. Zagury et al., HIV-1-INDUCED IMMUNE SUPPRESSION MAY RESULT FROM AUTOIMMUNE DISORDERSINCLUDING ANTI-SLWDQ AUTOANTIBODIES, Biomedicine & pharmacotherapy, 47(2-3), 1993, pp. 93-99
Citations number
31
Categorie Soggetti
Pharmacology & Pharmacy","Medicine, Research & Experimental
We have previously unravelled the striking SLWDQ pentapeptide identity
between HIV-1 env gp120 and the CD4 molecule. We show here that this
pentapeptide is required for the functioning of the co-stimulatory MHC
-CD4 signal in T4-cell activation since it suppresses antigen-induced
T-cell proliferation. Moreover, concerning the MHC class II counterpar
t, the LNGQEETGVVSTN sequence which strongly inhibits T-cell immune ac
tivation is likely to be part of the functional site of the molecule.
Interestingly the MHC/gp120 homology described by Young overlaps this
MHC region. We further report that the gp120 SLWDQ peptide triggers an
immune reaction which is both humoral (anti-SLWDQ antibodies) and cel
lular (CTLs against autologous targets carrying the pentapeptide) in H
IV-1 infected individuals. Finally, anti-SLWDQ antibodies from patient
s sera purified by column chromatography strongly inhibit antigen-indu
ced immune T-cell activation. This result led us to postulate that the
se antibodies found in high titers in HIV-1 infected individuals could
contribute to set up the progressive systemic immune T-cell suppressi
on characterizing AIDS.